Results 11 to 20 of about 78,453 (209)
Journal of Medical Case Reports, 2018 Background Incidences of immune thrombocytopenic purpura occur in 1 in every 1000–10,000 pregnancies accounting for 3% of all thrombocytopenic pregnancies.
Naser Al-Husban, Oqba Al-Kuran
doaj +2 more sources
Haematologica, 2019 Immune-mediated thrombotic thrombocytopenic purpura is characterized by severe thrombocytopenia and microangiopathic hemolytic anemia. It is primarily caused by immunoglobin G type autoantibodies against ADAMTS13, a plasma metalloprotease that cleaves ...
Elizabeth M. Staley +10 more
doaj +2 more sources
Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
Journal of Clinical Medicine, 2021 Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and ischemic end organ injury due to microvascular platelet-rich thrombi.
S. Sukumar, B. Lämmle, S. Cataland
semanticscholar +1 more source
Immune Thrombocytopenic Purpura in a Patient with Covid-19
New England Journal of Medicine, 2020 Immune Thrombocytopenic Purpura and Covid-19 Immune thrombocytopenia with lower-extremity purpura, mucosal bleeding, and cerebral microhemorrhage developed during the clinical course in a 65-year-o...
A. Zulfiqar +3 more
semanticscholar +1 more source
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura
Journal of Thrombosis and Haemostasis, 2020 Despite an increase in our understandings of pathogenesis of thrombotic thrombocytopenic purpura (TTP), the approaches for initial diagnosis and management of TTP vary significantly.
X. L. Zheng +13 more
semanticscholar +1 more source
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
Journal of Thrombosis and Haemostasis, 2020 Despite advances in treatment options for thrombotic thrombocytopenic purpura (TTP), there are still limited high quality data to inform clinicians regarding its appropriate treatment.
X. L. Zheng +13 more
semanticscholar +1 more source
Journal of Thrombosis and Haemostasis, 2020 Despite advances in treatment options for thrombotic thrombocytopenic purpura (TTP), there are still limited high quality data to inform clinicians regarding its management.
X. L. Zheng +13 more
semanticscholar +1 more source
Thrombocytopenic purpura as only manifestation of brucellosis in a child
The Turkish Journal of Pediatrics, 2004 Thrombocytopenic purpura associated with brucellosis has been rarely reported in the world literature. Thrombocytopenic purpura is generally part of the array of manifestations of brucellosis such as fever, arthritis, malaise and ...
Mehmet Yalaz +2 more
doaj +1 more source
Thrombotic thrombocytopenic purpura [PDF]
memo - Magazine of European Medical Oncology, 2018 Thrombotic thrombocytopenic purpura (TTP) is a clearly defined entity of the thrombotic microangiopathies (TMA), a heterogeneous group of disorders characterized by microangiopathic hemolytic anemia with red cell fragmentation, thrombocytopenia and organ dysfunction due to disturbed microcirculation.
openaire +3 more sources
Balkan Medical Journal, 2018 Background: Thrombotic thrombocytopenic purpura is a potentially life-threatening condition. Although the introduction of therapeutic plasma exchange has reduced mortality rates from over 90% to 10%-20%, approximately 40% of patients relapse, and ...
Seniz Öngören +9 more
doaj +1 more source